{"disease":{"id":"erythrodysesthesia-syndrome","name":"erythrodysesthesia syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05327751","title":"Possible Protective Effect of Celecoxib Against Capecitabine Induced Hand and Foot Syndrome in Patients With Colorectal Cancer","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":44,"lead_sponsor_name":"Tanta University","has_results":false},{"nct_id":"NCT05337423","title":"Photobiomodulation in the Treatment of Hand-foot Syndrome","phase":"NA","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"University of Nove de Julho","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}